Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 19, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Intracerebral HemorrhageIschemic StrokeSpironolactone
Interventions
DRUG

Spironolactone Pill

Participants randomized to the Spironolactone arm will be receiving Spironolactone in addition to their normal routine blood pressure treatment.

Trial Locations (5)

19104

RECRUITING

Hospital of the University of Pennsylvania, Philadelphia

19140

RECRUITING

Temple University Hospital, Philadelphia

27157

RECRUITING

Wake Forest Baptist Health, Winston-Salem

77030

RECRUITING

University of Texas Health Science Center at Houston, Houston

06512

RECRUITING

Yale New Haven Hospital, New Haven

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Yale University

OTHER